Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
9.69
-0.10 (-1.02%)
Nov 21, 2024, 4:00 PM EST - Market closed
Neumora Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1,566 | 2,604 | - | - | - | - |
| Enterprise Value | 1,243 | 2,090 | - | - | - | - |
| Last Close Price | 9.79 | 17.05 | - | - | - | - |
| PB Ratio | 4.90 | 5.55 | - | - | - | - |
| P/TBV Ratio | 6.59 | 5.55 | - | - | - | - |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | - |
| Quick Ratio | 10.75 | 18.12 | 15.73 | 17.59 | 20.50 | - |
| Current Ratio | 10.98 | 19.05 | 16.37 | 17.85 | 20.69 | - |
| Return on Equity (ROE) | -70.48% | -54.49% | -32.67% | -80.18% | -106.02% | - |
| Return on Assets (ROA) | -34.92% | -25.50% | -17.95% | -16.01% | - | - |
| Return on Capital (ROIC) | -37.20% | -26.74% | -18.92% | -16.85% | -16.97% | - |
| Earnings Yield | -18.67% | -9.06% | - | - | - | - |
| FCF Yield | -11.75% | -6.28% | - | - | - | - |
| Buyback Yield / Dilution | -368.32% | -138.99% | -24.25% | -68.46% | - | - |
| Total Shareholder Return | -368.32% | -138.99% | -24.25% | -68.46% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.